Skip to content

Laëtitia Bénard

Partner

Paris

Benard Laetitia
Laëtitia Bénard

Partner

Paris

Laëtitia leads the Paris Intellectual Property practice and is co-head of Allen & Overy's Life Sciences Group worldwide. Laëtitia is a litigator specializing in domestic and cross-border patent litigation.

She has a wealth of expertise in all intellectual property areas, more particularly having acted in numerous complex patent disputes involving pharmaceutical and high tech companies. She also advises on patent portfolios, patent validity, and freedom to operate issues. She has specific knowledge of the life sciences field, in which she also advises on various regulatory and contractual matters such as price regulation, advertisement for medicines, transfers of technology and anti-bribery rules. 

Laëtitia frequently publishes on life sciences regulatory topics and has written a number of clients alerts on issues such as biosimilars, the-EFPIA-Transparency-Initiative, and the online sale of medicines. Her publications include "Interim injunctions over patents – The French practice" in Managing Intellectual Property (February 2013); "Overview of Life Sciences law in France" in Chambers Life Sciences Guide 2013; "Why France is a good forum for preliminary injunctions in patent matters" in Global Business Magazine, 2012; "Supplementary Protection Certificates – CJEU provides welcome clarifications" International Who's Who Legal - Life Sciences, 2012; "Preliminary injunctions in Europe: an overview in the field of patents", The Handbook of European IP Management, 2012.

Laëtitia is a recognised practitioner by « Best Lawyers » since 2013 in Biotechnology and Life Sciences Practice, Intellectual Property Law, Litigation and Regulatory Practice".

Patent Litigator of the Year: Pharmaceuticals
LMG Life Sciences EMEA Awards 2023

“Laëtitia is the absolute top practitioner in her life science niche. She has unparalleled expertise worldwide in certain active ingredients.” “She defends for some of the world’s most renowned pharmaceutical innovators against generic competitors.”
IAM Patent 1000 2023 - France (IP/Patent)

Gold
IAM Patent 1000 2023 - France (IP/Patent)

Patent Litigator of the Year: Pharmaceuticals
LMG Life Sciences EMEA Awards 2023

Thought Leader - Global Leader – National Leader
Who's Who Legal 2023 – France in Patents and Life Sciences

"Laëtitia Bénard remains a key name in the market and is recognised for her expertise in domestic and multi-jurisdictional patent litigations. She represents leading global pharmaceutical companies in proceedings at the French and European level."

"Laëtitia can deal with complex litigation, she knows the French court system Inside out and is a very good strategic litigator."
Chambers Global/Europe 2023 - France (Pharma / Life Sciences)

Band 1
Chambers Global/Europe 2023 - France (Intellectual Property: Patents)

Laëtitia Bénard demonstrates leading experience in contentious patent mandates, including infringement claims and nullity actions. Her vast experience in the life sciences field means that she is regularly sought after by major pharmaceutical companies.

"She is one of the best lawyers I have dealt with in France. She is very creative and proactive, extremely thorough, sensible in her advice and is successful in tough cases."

"We appreciate her strategic vision of the cases and her very reassuring approach."

"She is one of the best lawyers of her generation."
Chambers Global/Europe 2023 - France (Intellectual Property: Patents)

Leading individual
Legal 500 EMEA 2023 - France (Healthcare & Life Sciences)

Hall of Fame
Legal 500 EMEA 2023 - France (Intellectual Property: Patents)

"Laetitia Bénard is a wonderful advocate. Dedicated to her clients, bright, demanding, determined. Top choice in France in the pharma sector."
Legal 500 EMEA 2023 - France (Intellectual Property: Patents)

Band 1 (Pharma/Life Sciences: Intellectual Property)
Chambers Global/Europe 2022 - France (Pharma / Life Sciences)

"Laëtitia Bénard remains a key name in the market and is recognised for her expertise in domestic and multi-jurisdictional patent litigations. She represents leading global pharmaceutical companies in proceedings at the French and European level. A client stresses that she is "thorough, sophisticated and an all-around fantastic lawyer."
Chambers Global/Europe 2022 - France (Pharma / Life Sciences)

Band 1
Chambers Global/Europe 2022 - France (Intellectual Property: Patents)

"Laëtitia Bénard is "one of the leaders on the market," according to sources. She demonstrates strong experience in contentious patent mandates and nullity actions. Clients report: 'She is thorough and is a good advocate in court and hearings,' further adding: 'She is active and successful'."
Chambers Global/Europe 2022 - France (Intellectual Property: Patents)

Hall of Fame
Legal 500 EMEA 2022 - France (Healthcare & Life Sciences)

"Laetitia has raised novel factual and legal arguments that had not been made elsewhere, and her arguments have been used by the attorneys in the other countries where related cases were pending."
Legal 500 EMEA 2022 - France (Healthcare & Life Sciences)

Leading Individual
Legal 500 EMEA 2022 - France (Intellectual Property: Patents)

"Laetitia Bénard is a wonderful advocate. Dedicated to her clients, bright, demanding, determined. Top choice in France in the pharma sector."
Legal 500 EMEA 2022 - France (Intellectual Property: Patents)

Silver for Enforcement and Litigation
Silver for Prosecution and Strategy
WTR1000 2022 - France (IP / Trademark)

Recommended Individual
Juve Patent 2022 - France (IP / Patent)

Patent star 2021 
Top 250 Women in IP 2021
Trade mark star 2021
Managing IP 2021 - France (Intellectual Property)

Gold
IAM Patent1000 2021 - France (IP/Patent)

"Laëtitia Bénard remains a key name in the market and is recognised for her expertise in domestic and multi-jurisdictional patent litigations. She represents leading global pharmaceutical companies in proceedings at the French and European level." 
Chambers Europe 2021 - France (Pharma/Life Sciences)

"Laëtitia Bénard garners high praise from clients, who applaud her extensive experience and very good strategic knowledge. She is recognised for her expertise in patents and she often acts on patent-related litigations." 
Chambers Europe 2021 - France (Pharma/Life Sciences)

"Hall of Fame" 
Legal 500 EMEA 2021 - France (Intellectual Property: Patents)

"Laëtitia Bénard is always available, competent and one of the best lawyers in the field." 
Legal 500 EMEA 2021 - France (Healthcare & Life Sciences)

Top 250 Women in IP 2021
Managing IP 2021

Silver - Prosecution and Strategy 
WTR 1000 2021 - France (IP/Trademark)

Silver - Enforcement and Litigation 
WTR 1000 2021 - France (IP/Trademark)

Recommended Individual
JUVE Patent 2021 - France (IP/Patent)

Trade mark star
IP Stars - Rising Stars 2020/2021 - France (Trade mark contentious)

Patent Lawyer of the Year
Women in Business Law Awards 2021 - Europe

Leading individual in patent litigation
Juve Patent 2021 - France

Ranked Silver for Enforcement & Litigation and Prosecution & Strategy
World Trademark Review 1000, 2021

"Esteemed litigator and firm board member"
World Trademark Review 1000, 2021

Intellectual Property Lawyer of the Year in France
Global Law Experts, 2021

Life Sciences Lawyer of the Year in France
Global Law Experts, 2021

Domestic and Cross-Border Patent Litigation Lawyer of the Year in France
Global Law Experts, 2021

Elite practitioner in IP
World IP Review, Leaders Guide, 2021

Intellectual Property Lawyer of the Year in France
Corporate International Global Awards, 2021

Life Sciences Lawyer of the Year in France
Corporate International Global Awards, 2021

Domestic and Cross-Border Patent Litigation Lawyer of the Year in France
Corporate International Global Awards, 2021

Global Leader
IAM Patent, 2021

Patent star
IP Star 2020-2021

Top 250 Women in IP 2020
IP Star 2020-2021

Trade mark star 2020/21
IP Star 2020-2021

Life Sciences Lawyer of the Year in France
Corporate Intl Global Awards 2021 

Lawyer of the Year in Intellectual Property Law 
Best Lawyers Awards - France 2021

"Laëtitia Bénard leads the charge and regularly appears in high-profile international patent suits, most recently on behalf of Novartis. The co-head of Allen & Overy’s worldwide life sciences group is noted for her unique ability to advise on pharmaceutical regulatory issues and their interplay with intellectual property." 
IAM Patent 1000 2020 - France

Laëtitia Bénard - Ranked Gold in Litigation 
IAM Patent 1000 2020 - France

Best Lawyer in France in Biotechnology and Life Sciences - Intellectual Property Law 
Best Lawyers 2020

Life Sciences Firm of the Year (France)
LMG Life Sciences Awareds Europe 2020

"Very strong in pharma proceedings” 
Juve – France 2020 

"Leading Individual"
Legal 500 EMEA 2020 – France (INTELLECTUAL PROPERTY: PATENTS)

"Laëtitia Bénard, the doyenne of life sciences litigation on behalf of originators, displays bulldog determination to win. She is a real fighter, creative, superb in court, producer of erudite submissions and a delight to work with." 
Legal 500 EMEA 2020 – France (INTELLECTUAL PROPERTY: PATENTS)

"Laëtitia Bénard, with her team, is very experienced, in particular in patent/SPC matters in the pharmaceutical field. Respected, client-oriented, responsive, creative, pragmatic." 
Legal 500 EMEA 2020 – France (INTELLECTUAL PROPERTY: PATENTS)

"Leading Individual"
Legal 500 EMEA 2020 – France (HEALTHCARE & LIFE SCIENCES)

"Laëtitia Bénard works tirelessly. She has knowledge of pharmaceutical law, and also of biotech and computer law." 
Legal 500 EMEA 2020 – France (HEALTHCARE & LIFE SCIENCES)

"Laëtitia Bénard, who co-heads the firm's life sciences group worldwide, is second to none in patent litigation." 
Legal 500 EMEA 2020 – France (HEALTHCARE & LIFE SCIENCES)

Laëtitia Bénard ranked Silver for Enforcement and Litigation, as well as Prosecution and Strategy 
WTR1000 2020

Band 1
Chambers Global/Europe 2020 - France (Intellectual Property)

The "fantastic" Laëtitia Bénard regularly acts for high-profile clients from the pharmaceutical industry on contentious patent mandates. She draws high praise from clients, one of whom states: "She is a top IP lawyer in the pharmaceutical world. She is determined, hard-working and a superb advocate." 
Chambers Global/Europe 2020 - France (Intellectual Property)

Band 1
Chambers Global/Europe 2020 - France (Pharma/Life Sciences: Intellectually Property)

The "extremely talented" Laëtitia Bénard is renowned as a patent litigator, most notably acting for high-profile pharmaceutical companies. One source says she is "very knowledgeable," before going on to add that she has a "very good grasp of IP enforcement in France." 
Chambers Global/Europe 2020 - France (Pharma/Life Sciences: Intellectually Property)

Leader
IAM Global Leaders Guide 2020

Global leader in Patents 
Who's Who Legal 2020

"Litigator Laëtitia Bénard heads both the IP practice in Paris and Allen & Overy’s life sciences group globally, gathering plaudits from the market for her finely tuned high-tech and pharmaceutical advice." 
IAM Patent 1000 2019 - France

Laëtitia Bénard - Ranked Gold in Litigation 
IAM Patent 1000 2019 - France

Global Leader in Life Sciences - Patent Litigation 2019, Patents 2019 and National Leader France - Life Sciences, France - Patents 
Who's Who Legal 2019

Silver for enforcement and litigation; prosecution and strategy 
WTR 1000- 2018-2019 

Leading Individual 
LEGAL 500 EMEA 2018-2019 – France (Intellectual Property: Patents) 

"Best in Patent" 
Euromoney LMG Europe Women in Business Law Awards 2019

"Intellectual Property Lawyer of the Year" 
Benchmark Litigation Europe 2019 

"Laëtitia Bénard specialises in pharmaceutical patent litigation and is lauded as "an excellent lawyer for contentious matters." Another source enthuses: "She is famous for being a hard-working, excellent lawyer for patent matters," adding: "She is a determined and effective presence in court."" 
Chambers 2019 - France (Pharma/Life Sciences)

"Laëtitia Bénard is a market leader in IP and primarily acts on patent litigation cases for pharmaceutical companies. She is highly respected by clients and peers who highlight her client dedication and industry knowledge. She assisted Pfizer with a patent litigation case concerning the validity of a second medical use patent." 
Chambers 2019 - France (Intellectual Property)

"Leading Life sciences practitioner in France." 
Euromoney Expert Guides: Best of the Best Global Awards 2019 

"Litigation Star for IP Litigation in France " 
Benchmark Europe 2019 

“IP Star” and “Top 250 Woman in IP”
Managing IP – Patents and Trademark 2018

“Laëtitia Bénard is described by clients as "very impressive" and "very knowledgeable about the pharmaceutical industry as a whole." She is further praised for her cross-border capabilities and her "pragmatic and result-oriented" nature.” 
Chambers Europe 2018 - France (Pharma/Life Sciences)

“Laëtitia Bénard is head of the firm's Paris IP practice. Clients say: "She is able to grasp complex issues and thinks about the big picture.” 
Chambers Europe 2018 - France (Intellectual Property)

"Peers shower Bénard with praise: ‘She’s an extremely hard worker with a tremendous reputation. Her importance in the IP scene is unquestionable.’.” 
IAM Patent 1000 2018 - France

“Pharmaceuticals powerhouse Bénard’s extremely impressive in court and has a strong understanding of procedural issues.” 
WTR 1000 2018

"Laëtitia is managing the team well," says a market commentator. According to one client, Bénard is "highly skilled in litigation". Another client adds: "Laëtitia is the go-to lawyer for life sciences companies and her skills are second to none."
Managing IP Europe 2018

Laëtitia Bénard heads the IP and litigation department: "She is incredibly capable, knows her cases extremely well, anticipates questions before they arise and has a complete grasp of all aspects of IP litigation issues in France". 
IAM Patent 1000 2017 - France

"Practice head Laëtitia Bénard is ‘very impressive and the must-use lawyer in the life sciences area’." 
Legal 500 EMEA 2017 – France (Intellectual Property: Patents)

"Laëtitia Bénard excels in all aspects of IP with a particular focus on the life sciences sector."  
Chambers Europe 2017 - France (Intellectual Property)

"Laëtitia Bénard is described as a 'very present and important' practitioner in the market. She has particular expertise in the life sciences sector." 
Who's Who Legal 2017 - France

Related articles

image of Gemma Barrett

News: 26 February 2024

Allen & Overy grows global IP practice with hire of life sciences specialist, Gemma Barrett

Allen & Overy (A&O) today announced that Gemma Barrett has joined the firm’s Intellectual Property practice as a specialist in life sciences. Gemma joins the firm from Bristows.

Read more Allen & Overy grows global IP practice with hire of life sciences specialist, Gemma Barrett

News: 30 November 2023

Allen & Overy boosts IP practice in Germany with hire of Anna Wolters-Höhne

Read more Allen & Overy boosts IP practice in Germany with hire of Anna Wolters-Höhne

News: 21 July 2023

A&O’s patent practices and lawyers secure top rankings in leading intellectual property platform

Read more A&O’s patent practices and lawyers secure top rankings in leading intellectual property platform

Blog Post: 28 November 2022

Webinar - EU developments in pricing and reimbursement

Read more Webinar - EU developments in pricing and reimbursement

Office

Paris

32 rue François 1er
75008
Paris

View office →

Qualifications

Professional

Admitted to the Bar, Paris, 2000

Academic

Post Graduate Degree, Industrial Property, University of Paris II Panthéon Assas, 1999

Post Graduate Degree, French Civil Law, University of Paris I Panthéon Sorbonne, 1998

Pro bono

  • Advising French non-profit organisation "Autistes Sans Frontières" ("Autistics Without Borders")

 

Published work

  • ‘Brexit’: time is of the essence for life sciences innovators – LSIPR (Life Sciences Intellectual Property Review) – June 2016
  • La juridiction unifiée du brevet (JUB) : un atout indéniable pour l'Europe, La Lettre des juristes d'affaires, July 2014
  • La juridiction unifiée du brevet (JUB) reçoit un soutien croissant des entreprises, Option Droit et Finance, July 2014 co-authored with David Por
  • France’s Biosimilar law may set trend inside the EU, Law 360, February 2014, co-authored with Eveline Van Keymeulen
  • L’Acte II de l’exception culturelle sur la scène du numérique, Les Echos, June 2013
  • "France" chapter, International Copyright Law book, Global Law & Business, May 2013, co-authored with Alexandre Rudoni and Olivia Klimis
  • Overview of Life Sciences law in France, Chambers Life Sciences Guide 2013, co-authored with Olivier Fréget, David Por and Olivia Klimis
  • Interim injunctions over patents, The French practice, Managing Intellectual Property, co-authored with Olivia Klimis
  • Choisir la stratégie juridique adéquate pour valoriser sa marque - Décryptage avec Laëtitia Bénard, Les Echos, December 2012
  • Comparative Advertising for generics in Germany and France after L’Oréal v Bellure, PTMG Law Lore & Practice, December 2012, co-authored with Oscar Benito, Rainer Kaase and Ralf Möller
  • Il faut sauver le projet de brevet unitaire européen, Option Droit & Affaires, September 2012, co-authored with Olivia Klimis
  • Preliminary injunctions in Europe: an overview in the field of patents, The Handbook of European IP Management, May 2012
  • Trade secrets protection: a comparative overview, The Handbook of European IP Management, May 2012, co-authored with  Benjamin Bai and Paul B. Keller
  • Why France is a good forum for preliminary injunctions in patent matters, Global Business Magazine, April 2012
  • Supplementatry protection certificates: CJEU provides welcome clarifications, Who's Who Legal, Life Sciences, April 2012, co-authored with Olivia Klimis
  • Trade secrets protection, Commerce International, April 2012
  • L'arrêt DHL/Chronopost de la CJUE du 12 avril 2011 : une injonction communautaire peut être obtenue dans les limites de l'atteinte aux fonctions de la marque, Revue Lamy Droit de l'immatériel, August/September 2011, co-authored with Alexandra Abello
  • Competition, Public Health, Innovation and Drugs, LGDJ, 2010, under the supervision of Marie-Anne Frison-Roche
  • Generic drugs and IP law, Lamy Droit de la Santé, 2002, 2004 and 2008
  • Question 202 of the AIPPI French group on "The impact of public health issues on exclusive patents rights", September 2008
  • The DADVSI law regarding television: three steps backward for right owners?, Legipresse, May 2007, co-authored with Alexandre Rudoni
  • Rights owners and users fail to agree on reform, Managing Intellectual Property, June 2006, co-authored with Alexandre Rudoni
  • How to prepare the businessmen in the biotechnology sector for the cession of their firm, Bio Futur, October 2005, co-authored with Alexandre Rudoni